Furthermore, it provides a conceptual basis for tiered remediation strategies in mixed-species consortia or sequential treatment configurations ( A
## Availability Status: March 2026 - **FDA status:** Phase 3 clinical trials ongoing - **Expected approval timeline:** Potentially 2026-2027 - **Brand availability:** None yet - **Current access:** Compounding pharmacies (503A/503B) with valid prescription For a detailed breakdown of [retatrutide's FDA approval status and projected timeline](/guides/retatrutide-fda-approval-2026-timeline-status), see our dedicated tracker the date brand pricing becomes available depends directly on when retatrutide clears FDA review
If this symptom persists beyond the initial adjustment period, speaking with your healthcare provider is recommended
PlexusDx partners with licensed 503A compounding pharmacies to deliver semaglutide injections starting at just $189/mo (or $149/mo on the 6-month plan), regardless of dose escalationmeaning patients never pay more as their dose increases
On average, 33% of Hispanic adults are obese, while 41% of Black adults are considered obese
Fortified grains and cereals